Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products

被引:138
作者
Ohgami, N
Nagai, R
Miyazaki, A
Ikemoto, M
Arai, H
Horiuchi, S
Nakayama, H
机构
[1] Kumamoto Univ, Sch Med, Dept Biochem, Kumamoto 8600811, Japan
[2] Kumamoto Univ, Fac Pharmaceut Sci, Dept Biofunct Chem, Kumamoto 8620973, Japan
[3] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Bunkyo Ku, Tokyo 1130033, Japan
关键词
D O I
10.1074/jbc.M011613200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cellular interactions of advanced glycation end products (AGE) are mediated by AGE receptors, We demonstrated previously that class A scavenger receptor types I and II (SR-A) and CD36, a member of class B scavenger receptor family, serve as the AGE receptors, In this study, we investigated whether scavenger receptor class B type I (SR-BI), another receptor belonging to class B scavenger receptor family, was also an AGE receptor. We used Chinese hamster ovary (CHO) cells overexpressed hamster SR-BI (CHO-SR-BI cells). I-125-AGE-bovine serum albumin (AGE-BSA) was endocytosed in a dose-dependent fashion and underwent lysosomal degradation by CHO-SR-BI cells. I-125-AGE-BSA exhibited saturable binding to CHO-SR-BI cells (K-d = 8.3 mug/ml). Endocytic uptake of I-125-AGE-BSA by CHO-SR-BI cells was completely inhibited by oxidized low density lipoprotein (LDL) and acetylated LDL, whereas LDL exerted only a weak inhibitory effect (<20%). Cross-competition experiments showed that AGE-BSA had no effect on HDL binding to these cells and vice verse. Interestingly, however, SR-BI-mediated selective uptake of HDL-CE was completely inhibited by AGE-BSA in a dose-dependent manner (IC50 <10 mug/ml). Furthermore, AGE-BSA partially inhibited (by <30%) the selective uptake of HDL-CE in human hepatocarcinoma HepG2 cells (IC50 <30 mug/ml). In addition, [H-3]cholesterol efflux from CHO-SR-BI cells to HDL was significantly inhibited by AGE-BSA in a dose-dependent manner (IC50 <30 <mu>g/ml), Our results indicate that AGE proteins, as ligands for SR-BI, effectively inhibit both SR-BI-mediated selective uptake of HDL-CE and cholesterol efflux from peripheral cells to HDL, suggesting that AGE proteins might modulate SR-BI-mediated cholesterol metabolism in vivo.
引用
收藏
页码:13348 / 13355
页数:8
相关论文
共 72 条
[31]   Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat [J].
Landschulz, KT ;
Pathak, RK ;
Rigotti, A ;
Krieger, M ;
Hobbs, HH .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :984-995
[32]   Molecular identity and cellular distribution of advanced glycation endproduct receptors: Relationship of p60 to OST-48 and p90 to 80K-H membrane proteins [J].
Li, YM ;
Mitsuhashi, T ;
Wojciechowicz, D ;
Shimizu, N ;
Li, J ;
Stitt, A ;
He, CJ ;
Banerjee, D ;
Vlassara, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :11047-11052
[33]  
Ling X, 1998, LAB INVEST, V78, P1591
[34]   TOXICITY OF MILDLY MODIFIED LOW-DENSITY LIPOPROTEINS TO CULTURED RETINAL CAPILLARY ENDOTHELIAL-CELLS AND PERICYTES [J].
LYONS, TJ ;
LI, W ;
WELLSKNECHT, MC ;
JOKL, R .
DIABETES, 1994, 43 (09) :1090-1095
[35]  
Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66
[36]  
MAKITA Z, 1992, J BIOL CHEM, V267, P5133
[37]   Endocytic uptake of advanced glycation end products by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor class A [J].
Matsumoto, K ;
Sano, H ;
Nagai, R ;
Suzuki, H ;
Kodama, T ;
Yoshida, M ;
Ueda, S ;
Smedsrod, B ;
Horiuchi, S .
BIOCHEMICAL JOURNAL, 2000, 352 :233-240
[38]   IMMUNOCHEMICAL DETECTION OF ADVANCED GLYCATION END-PRODUCTS IN RENAL-CORTEX FROM STZ-INDUCED DIABETIC RAT [J].
MITSUHASHI, T ;
NAKAYAMA, H ;
ITOH, T ;
KUWAJIMA, S ;
AOKI, S ;
ATSUMI, T ;
KOIKE, T .
DIABETES, 1993, 42 (06) :826-832
[39]   BETA(2)-MICROGLOBULIN MODIFIED WITH ADVANCED GLYCATION END-PRODUCTS IS A MAJOR COMPONENT OF HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS [J].
MIYATA, T ;
ODA, O ;
INAGI, R ;
IIDA, Y ;
ARAKI, N ;
YAMADA, N ;
HORIUCHI, S ;
TANIGUCHI, N ;
MAEDA, K ;
KINOSHITA, T .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) :1243-1252
[40]   INVOLVEMENT OF BETA(2)-MICROGLOBULIN MODIFIED WITH ADVANCED GLYCATION END-PRODUCTS IN THE PATHOGENESIS OF HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS - INDUCTION OF HUMAN MONOCYTE CHEMOTAXIS AND MACROPHAGE SECRETION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1 [J].
MIYATA, T ;
INAGI, R ;
IIDA, Y ;
SATO, M ;
YAMADA, N ;
ODA, O ;
MAEDA, K ;
SEO, H .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :521-528